Chk1 inhibition potentiates the therapeutic efficacy of PARP inhibitor BMN673 in gastric cancer

Globally, gastric cancer is the second leading cause of cancer deaths because of the lack of effective treatments for patients with advanced tumors when curative surgery is not possible. Thus, there is an urgent need to identify molecular targets in gastric cancer that can be used for developing nov...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Am J Cancer Res
Main Authors: Yin, Yuping, Shen, Qian, Zhang, Peng, Tao, Ruikang, Chang, Weilong, Li, Ruidong, Xie, Gengchen, Liu, Weizhen, Zhang, Lihong, Kapoor, Prabodh, Song, Shumei, Ajani, Jaffer, Mills, Gordon B, Chen, Jianying, Tao, Kaixiong, Peng, Guang
Formato: Artigo
Idioma:Inglês
Publicado: e-Century Publishing Corporation 2017
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5385637/
https://ncbi.nlm.nih.gov/pubmed/28401005
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares